Purdue Pharma files for bankruptcy; settlement to provide more $10B to address opioid crisis

STAMFORD, Conn.–(BUSINESS WIRE)–Purdue Pharma L.P. today announced that it has reached an agreement in principle on a framework for settling the U.S. opioid litigation facing the Company with 24 state attorneys general, analogous officials from 5 U.S. territories, the Plaintiffs’ Executive Committee in the multidistrict litigation (MDL), and co-lead counsel in the MDL.

Read more